Publicaties

Kiewik M, VanDerNagel JEl, Kemna L.E.M., Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: A cluster randomised control trial. Journal of Intellectual Disability Research. 60(3):191–200.

DeJong CA, De Fuentes-Merillas L, van de Werken F..  2016.  The US: An unidimentional measure of couple satisfaction. Relating Theory: Clinical, Forensic and Other Applications.

DeJong CA, DeFuentes-Merillas L, VandeWerken F, Birtchnell J.  2016.  The US as a Couple Questionnaire (US). A Unidimensional Measure of Couple Satisfaction. Relating Theory-Clinical and Forensic Applications. Eds: J. Birtchnell, M. Newberry, and A.E. Kalaitzaki.

Oliemeulen L.E.A.P., van de Ven P, Verbrugge CAG.  2016.  Wat is de visie op herstel bij verslaafde clienten . Verslaving anders bekijken.

Postel MG, Huurne ED ter, de Haan HA, van der Palen J, DeJong CA.  2015.  A 9-month follow-up of a 3-month web-based alcohol treatment program using intensive asynchronous therapeutic support.. Am J Drug Alcohol Abuse. 41(4):309-16.

Middeldorp J, Smit R, Post H, Koerts J, van Oene GH de Weert.  2015.  Aandacht voor somatiek bij verslaafden. Verslaving. 11

DeJong CA, Luycks L.  2015.  Addiction medicine training in the Netherlands. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. . XII

Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E.  2015.  Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.. Transl Psychiatry. 5:e626.

Kok T, de Haan HA, van der Meer M, Najavits L, DeJong CA.  2015.  Assessing traumatic experiences in screening for PTSD in substance use disorder patients: What is the gain in addition to PTSD symptoms? Psychiatry Res. 226(1):328-32.

López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A.  2015.  Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med. 45(6):1121-33.

Kamal RM, Qurishi R, DeJong CA.  2015.  Baclofen and γ-Hydroxybutyrate (GHB), a Dangerous Combination.. J Addict Med. 9(1):75-7.

Kamal RM, Schellekens A, DeJong CA, Dijkstra BAG.  2015.  Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.. BMC Psychiatry. 15:91.

Kamal RM, Loonen AJ, Dijkstra BAG, DeJong CA.  2015.  Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: a case series.. J Clin Psychopharmacol. 35(3):313-8.

Kisjes H., Verbrugge C, DeJong CA.  2015.  Begeleiding en behandeling bij verslavingsproblematiek. Psychiatrie voor verpleegkundigen. :253-273.

Emmelkamp P.M.G., Merkx M.JM, De Fuentes-Merillas L.  2015.  Contingency Management. Gedragstherapie. 48(2):153-170.

Domínguez I, Bruguera P, Balcells-Oliveró M, Batalla A.  2015.  Depression Following γ-Hydroxybutyrate Withdrawal: A Case Report.. J Clin Psychopharmacol.

Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  The development of an National Training Program on Addiction Medicine in Indonesia. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. XII

Ter Huurne ED, de Haan HA, Napel-Schutz MC ten, Postel MG, Menting J, van der Palen J, Vroling MS, DeJong CA.  2015.  Is the Eating Disorder Questionnaire-Online (EDQ-O) a valid diagnostic instrument for the DSM-IV-TR classification of eating disorders? Comprehensive Psychiatry. 57

El-Guebaly N., DeJong CA.  2015.  Education and Training: An Introduction. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. XII:2377-2379.

Burger DM, De Mast Q, Schellekens A.  2015.  Efavirenz en risico op zelfmoord bij hiv-patiënten. Ned Tijdschr Geneeskd. 159

Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  Effectiveness and Organization of Addiction Medicine Training Across the Globe.. Eur Addict Res. 21(5):223-39.

Markus W, Hornsveld H.  2015.  EMDR en verslaving. Praktijkboek EMDR, deel II. Toepassingen voor nieuwe patientengroepen en stoornissen..

Rietveld J, Hoek T, van Beek M, Schellekens A.  2015.  Familial liability for metoprolol-induced psychosis. General Hospital Psychiatry. 37(6):Pages620.e5–620.e6.

Mothapo KM, Schellekens A, Van Crevel R, Keuter M, Grintjes-Huisman K, Koopmans P, van der Ven A.  2015.  Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment. CNS & Neurological Disorders - Drug Targets. 14(6):811-818(8).

Qurishi R., Arts-DeJong M., Franzek E.J., Hartman L., DeJong CA.  2015.  Influence of Premenstrual Syndrome on Relapse in Nicotine Abuse a Case Report. Austin Journal of Drug Abuse and Addiction. 2(1)